| |
|
|
|
Anavex Life Sciences Corp.  
|
|
3.5539 -0.006 (-0%) |
05-24 09:43 |
|
Open: |
3.62 |
Pre close: |
3.56 |
Target:
|
4.61
|
|
High: |
3.62 |
Low: |
3.54 |
Resistance:
|
3.95
4.61
|
|
Volume: |
13,490 |
Market Cap: |
175M |
Support:
|
3.21
2.75
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.55
 |
MACD |
MACD(12,26):
|
0.16 |
|
MA(20): |
3.24 |
Signal(12,26,9): |
0.12 |
|
MA(100): |
2.64 |
Stochastic Oscillator |
%K(14,3):
|
68.11  |
|
MA(250): |
2.69 |
%D(3): |
71.64 |
|
Average Volume(K) |
3-Month: |
43148
|
52-Week |
High:
|
4.35 |
|
10-Days: |
59277 |
Low: |
1.25 |
|
RSI |
RSI(14):
|
65.37 |
Change(%): |
31.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.460 |
Return on Equity (ttm) |
-130.9 |
Shares Out. (M) |
49.12 |
|
EPS Est. Current Year |
-0.370 |
Return on Assets (ttm) |
-103.3 |
Shares Float (M) |
38.98 |
|
EPS Est. Next Year |
-0.450 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
20.40 |
|
Forward EPS |
-0.480 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
11.950 |
EBITDA (p.s.) |
0.000 |
P/E |
-7.74 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.30 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
